跳至主要内容
临床试验/NCT03480945
NCT03480945已完成不适用

Evaluation of the Mechanism Underlying Endothelial Dysfunction in Patients With Type 2 Diabetes With Poor and Optimized Glycaemic Control

Karolinska Institutet1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2016年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
16
试验地点
1
主要终点
Endothelial function

研究概览

简要总结

Study objective To evaluate the mechanism behind endothelial dysfunction in patients with type 2 diabetes in relation to the level of glycaemic control.

Primary endpoint: Change in endothelium dependent vasodilatation (EDV).

详细描述

The study is performed on one group of patients with type 2 diabetes and one group of age-matched healthy controls

Inclusion criteria:

  1. Type 2 diabetes
  2. Poor glycaemic control defined as a mean day blood glucose >12 mmol/L.

Exclusion criteria:

  1. Age >80 years.
  2. HbA1c <70 mmol/mol
  3. Myocardial infarction/unstable angina within 6 weeks prior to the study.
  4. Treatment with oral anticoagulants (Warfarin or New oral anticoagulants)
  5. Raynaud's phenomenon, peripheral vasculopathies, arterial shunting or other vascular surgery of the study arm.
  6. Any concomitant disease or condition that may interfere with the possibility for the patient to comply with or complete the study protocol.
  7. Participant in an ongoing study.
  8. Unwillingness to participate following oral and written information.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Type 2 diabetes
  • •Poor glycaemic control defined as a mean day blood glucose >12 mmol/L.

排除标准

  • •Age >80 years.
  • •HbA1c <70 mmol/mol
  • •Myocardial infarction/unstable angina within 6 weeks prior to the study.
  • •Treatment with oral anticoagulants (Warfarin or New oral anticoagulants)
  • •Raynaud's phenomenon, peripheral vasculopathies, arterial shunting or other vascular surgery of the study arm.
  • •Any concomitant disease or condition that may interfere with the possibility for the patient to comply with or complete the study protocol.
  • •Participant in an ongoing study.
  • •Unwillingness to participate following oral and written information.

结局指标

主要结局

Endothelial function

时间窗: 8 weeks

Change in endothelium-dependent dilatation

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

John Pernow

professor

Karolinska Institutet

研究点 (1)

Loading locations...

相似试验